With more people using PrEP every month, AVAC and its HIV Prevention Market Manager project has created the Global PrEP Tracker to help keep track of the fast-changing status of PrEP around the world.
PrEP Brasil was a demonstration study to assess feasibility of daily oral tenofovir diphosphate disoproxil fumarate plus emtricitabine provided at no cost to men who have sex with men (MSM) and transgender women at high risk for HIV within the Brazilian public health system.
They are marching, writing lesson plans, changing the signs on bathroom doors and, alongside their students, pushing colleagues and school administrators and elected officials to improve awareness of gender issues.
The United Nations is calling for a transparent, independent investigation into the assassination of the Black activist and city councilwoman in Rio de Janeiro.
